Results 151 to 160 of about 47,532 (242)

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II) [PDF]

open access: hybrid, 2013
Caroline M. Apovian   +7 more
openalex   +1 more source

Neuroendocrinology meets addiction: Emerging pharmacotherapies on the horizon

open access: yesJournal of Internal Medicine, Volume 298, Issue 5, Page 392-423, November 2025.
Abstract Alcohol and other substance use disorders (ASUDs) are prevalent and major contributors to global morbidity and mortality. Their impact extends beyond the individual, imposing significant burdens on families, communities, healthcare systems, and society at large.
Anna Loften   +3 more
wiley   +1 more source

Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials [PDF]

open access: hybrid, 2011
David P. King   +8 more
openalex   +1 more source

Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2016
S. Nissen   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy